This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Pharma Foods International Co., Ltd., Kyoto Prefectural Public University Corporation, Pharma Foods International Co., Ltd.. Active years: 2021-2026.
Company Filing History:
2 out of 10 
1 out of 60 
1 out of 3 Years Active: 2021-2026
Title: Utano Nakamura: Innovator in Osteogenesis and Joint Health
Introduction
Utano Nakamura is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of medicine and health through his innovative research and development of therapeutic agents. With a total of 3 patents, his work focuses on improving the quality of life for individuals suffering from various bone and joint disorders.
Latest Patents
Nakamura's latest patents include a preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases. This agent is designed to prevent and treat conditions such as osteoporosis and osteoarthritis. It comprises a peptide with specific amino acid sequences that can be orally ingested, promoting osteogenic function and aiding in the healing of bone fractures. His second patent involves a hyaluronic acid production promoting agent derived from poultry feet. This agent is effective in preventing or treating joint disorders and improving skin conditions, making it useful in various applications, including medicaments and cosmetics.
Career Highlights
Nakamura is associated with Pharma Foods International Co., Ltd., where he continues to advance his research. His work has garnered attention for its potential to revolutionize treatments for bone and joint health.
Collaborations
He collaborates with notable colleagues, including Mujo Kim and Chihiro Suzuki, who contribute to his innovative projects and research endeavors.
Conclusion
Utano Nakamura's contributions to medical science through his patents highlight his dedication to improving health outcomes for individuals with bone and joint disorders. His innovative approaches continue to pave the way for future advancements in therapeutic agents.